Having its values constantly in evolution assertive of economic and productive development, searching for cutting-edge technology in its mixtures, we developed the Y Mixer for pharmaceutical premixes, acting in national and multinational laboratories.
Working in the production of industrial equipment in stainless steel 304 and 316L and carbon steel SAE 1020 and 1010. We design and develop according to customer's orientations, with densities from 0.2 to 3.5 g / cm³, with excellent cost / benefit, quality and warranty.
Homogenization of several components with variable physical characteristics, forming a resulting product of uniform composition in any sample collected; Ideal to avoid contamination as well as degradation of the constituents of the product.
Consisting of three confluent Y-shaped tubes that perform rotary movements for separation and cyclic re-encounters of the materials, providing the mixture;
· Accessibility for cleaning;
· Capacities from 50 to 1,000L;
· Smooth handling of material;
Contact! ask for a quote, we are waiting for your call!
_______________________________________________________________
"Brazil has excellence in scientific research" says president of the Servier group. "
The project is based on natural extracts from a collection of 6,000 plants that Fiocruz has had for 30 years. We will try to identify active substances for the treatment of several types of the disease. If there are positive results, Fiocruz will have the right to explore part of them in the public sphere, while we will explore them in the market.
Thus, French researchers from Servier came to Friocruz to analyze the first samples to evaluate the viability of the project. As we conclude that there is a high chance of active substances, we decided to implement the collaboration through a contract approved by Fiocruz's prosecutor a few weeks ago. We are at the stage of providing a therapeutic target to test the effectiveness of the substances.
If we develop a cancer treatment drug with it, we will be ready to share the production technology with SUS.
This is the first time we have done research on natural products, and Fiocruz has something that does not exist anywhere else in the world. The area of oncology is new to us. So that's one of the clues we're following.
Nenhum comentário:
Postar um comentário